Biomerica (BMRA) announced that it has been granted an additional 180-day compliance period from the Nasdaq Stock Market LLC to meet the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market. This extension allows Biomerica until May 5, 2025, to regain compliance.